Related references
Note: Only part of the references are listed.Germline BRCA variants, lifestyle and ovarian cancer survival
Kate Gersekowski et al.
GYNECOLOGIC ONCOLOGY (2022)
Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment
David A. Wheeler et al.
CANCER CELL (2021)
Characterization of patients with long-term responses to rucaparib treatment in recurrent ovarian cancer
Elizabeth M. Swisher et al.
GYNECOLOGIC ONCOLOGY (2021)
Twelve years of SAMtools and BCFtools
Petr Danecek et al.
GIGASCIENCE (2021)
Structural Variants at the BRCA1/2 Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma
Ailith Ewing et al.
CLINICAL CANCER RESEARCH (2021)
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al.
NATURE (2020)
Prognostic gene expression signature for high-grade serous ovarian cancer
J. Millstein et al.
ANNALS OF ONCOLOGY (2020)
pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens
Jasreet Hundal et al.
CANCER IMMUNOLOGY RESEARCH (2020)
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
R. E. Miller et al.
ANNALS OF ONCOLOGY (2020)
Pan-cancer landscape of homologous recombination deficiency
Luan Nguyen et al.
NATURE COMMUNICATIONS (2020)
NFATC4 promotes quiescence and chemotherapy resistance in ovarian cancer
Alexander J. Cole et al.
JCI INSIGHT (2020)
Impact of Smoking on Human Natural Killer Cell Activity: A Large Cohort Study
Yoon Suk Jung et al.
JOURNAL OF CANCER PREVENTION (2020)
A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies
Andrea Degasperi et al.
NATURE CANCER (2020)
Integrated structural variation and point mutation signatures in cancer genomes using correlated topic models
Tyler Funnell et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Determining cell type abundance and expression from bulk tissues with digital cytometry
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2019)
Going to extremes: determinants of extraordinary response and survival in patients with cancer
Flurina A. M. Saner et al.
NATURE REVIEWS CANCER (2019)
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
Yi-Mi Wu et al.
CELL (2018)
SvABA: genome-wide detection of structural variants and indels by local assembly
Jeremiah A. Wala et al.
GENOME RESEARCH (2018)
Who are the long-term survivors of high grade serous ovarian cancer?
Claire Hoppenot et al.
GYNECOLOGIC ONCOLOGY (2018)
Genome doubling shapes the evolution and prognosis of advanced cancers
Craig M. Bielski et al.
NATURE GENETICS (2018)
Strelka2: fast and accurate calling of germline and somatic variants
Sangtae Kim et al.
NATURE METHODS (2018)
Copy number signatures and mutational processes in ovarian carcinoma
Geoff Macintyre et al.
NATURE GENETICS (2018)
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
K. Moore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors
S. Y. Cindy Yang et al.
GENOME MEDICINE (2018)
Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer
Zsofia Sztupinszki et al.
NPJ BREAST CANCER (2018)
Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer
Dale W. Garsed et al.
CLINICAL CANCER RESEARCH (2018)
HYSYS: have you swapped your samples?
Jan Schroder et al.
BIOINFORMATICS (2017)
GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly
Daniel L. Cameron et al.
GENOME RESEARCH (2017)
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
Elizabeth M. Swisher et al.
LANCET ONCOLOGY (2017)
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
Yi Kan Wang et al.
NATURE GENETICS (2017)
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
Alejandro Jimenez-Sanchez et al.
CELL (2017)
Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications
Xiaoyu Chen et al.
BIOINFORMATICS (2016)
Ovarian Cancers Harboring Inactivating Mutations in CDK12 Display a Distinct Genomic Instability Pattern Characterized by Large Tandem Duplications
Tatiana Popova et al.
CANCER RESEARCH (2016)
RB localizes to DNA double-strand breaks and promotes DNA end resection and homologous recombination through the recruitment of BRG1
Renier Velez-Cruz et al.
GENES & DEVELOPMENT (2016)
FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing
Ronglai Shen et al.
NUCLEIC ACIDS RESEARCH (2016)
VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research
Zhongwu Lai et al.
NUCLEIC ACIDS RESEARCH (2016)
OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs
Jordan Anaya
PEERJ COMPUTER SCIENCE (2016)
Unified representation of genetic variants
Adrian Tan et al.
BIOINFORMATICS (2015)
HLA-VBSeq: accurate HLA typing at full resolution from whole-genome sequencing data
Naoki Nariai et al.
BMC GENOMICS (2015)
Does Aggressive Surgery Improve Outcomes? Interaction Between Preoperative Disease Burden and Complex Surgery in Patients With Advanced-Stage Ovarian Cancer: An Analysis of GOG 182
Neil S. Horowitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Whole-genome characterization of chemoresistant ovarian cancer
Ann-Marie Patch et al.
NATURE (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer
Rosemary D. Cress et al.
OBSTETRICS AND GYNECOLOGY (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer
Francisco J. Candido-dos-Reis et al.
CLINICAL CANCER RESEARCH (2015)
Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays
Martin J. Aryee et al.
BIOINFORMATICS (2014)
FLAGS, frequently mutated genes in public exomes
Casper Shyr et al.
BMC MEDICAL GENOMICS (2014)
Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
Kathryn P. Pennington et al.
CLINICAL CANCER RESEARCH (2014)
Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients? A nationwide Danish study
Carsten Lindberg Fago-Olsen et al.
GYNECOLOGIC ONCOLOGY (2014)
Ovarian Cancer-associated Mutations Disable Catalytic Activity of CDK12, a Kinase That Promotes Homologous Recombination Repair and Resistance to Cisplatin and Poly(ADP-ribose) Polymerase Inhibitors
Poorval M. Joshi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Functional normalization of 450k methylation array data improves replication in large cancer studies
Jean-Philippe Fortin et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
Weiva Sieh et al.
LANCET ONCOLOGY (2013)
Emerging landscape of oncogenic signatures across human cancers
Giovanni Ciriello et al.
NATURE GENETICS (2013)
Synthetic lethality between CCNE1 amplification and loss of BRCA1
Dariush Etemadmoghadam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
RSeQC: quality control of RNA-seq experiments
Liguo Wang et al.
BIOINFORMATICS (2012)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
Mutual exclusivity analysis identifies oncogenic network modules
Giovanni Ciriello et al.
GENOME RESEARCH (2012)
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Daniel C. Koboldt et al.
GENOME RESEARCH (2012)
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
Wei-Ting Hwang et al.
GYNECOLOGIC ONCOLOGY (2012)
Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
Kelly L. Bolton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
Kathryn Alsop et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic Agents
Weiwen Fan et al.
CANCER RESEARCH (2011)
Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
Barbara Norquist et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
Tom Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval
Peter C. Fong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
Allele-specific copy number analysis of tumors
Peter Van Loo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
rtracklayer: an R package for interfacing with genome browsers
Michael Lawrence et al.
BIOINFORMATICS (2009)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
Dariush Etemadmoghadam et al.
CLINICAL CANCER RESEARCH (2009)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
D. S. Chi et al.
GYNECOLOGIC ONCOLOGY (2006)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
